BioCardia to Present at the LD Micro 500 Virtual Conference on September 1, 2020
August 26 2020 - 7:00AM
BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development
of comprehensive solutions for cardiovascular regenerative
therapies today announced that Peter Altman, Ph.D., Biocardia’s
Chief Executive Officer will give a virtual corporate presentation
at the LD Micro 500 taking place online on Tuesday, September 1,
2020 at 10:20 AM ET followed by a live question and answer session
with registered investors and other conference attendees.
Webcast link:
https://www.webcaster4.com/Webcast/Page/2019/36064
In addition, Dr. Altman will be available for virtual one-on-one
meetings beginning on September 1, 2020 and through September 4,
2020. To schedule a meeting, please contact Eric Lahiji at
eric@ldmicro.com.
About BioCardia
BioCardia, Inc., headquartered in San Carlos, California, is
developing regenerative biologic therapies to treat cardiovascular
disease. CardiAMP autologous and Neurokinin-1 Receptor Positive
allogenic cell therapies are the Company’s biotherapeutic platforms
in clinical development. The Company's products include the Helix
Biotherapeutic Delivery System and its steerable guide and sheath
catheter portfolio. BioCardia also partners with other
biotherapeutic companies to provide its Helix system and clinical
support for their programs studying therapies for the treatment of
heart failure, chronic myocardial ischemia and acute myocardial
infarction. For more information, visit www.BioCardia.com.
Media Contact:Michelle McAdam, Chronic
Communications, Inc.michelle@chronic-comm.com(310) 902-1274
Investor Contact:David McClung, Chief Financial
OfficerInvestors@BioCardia.com(650) 226-0120
BioCardia (NASDAQ:BCDAW)
Historical Stock Chart
From Jun 2024 to Jul 2024
BioCardia (NASDAQ:BCDAW)
Historical Stock Chart
From Jul 2023 to Jul 2024